News Home

Where Will AcelRx Pharmaceuticals Inc (ACRX) Stock Go Next After It Is Up 31.65% in a Week?

Friday, May 26, 2023 11:03 AM | InvestorsObserver Analysts

Mentioned in this article

Where Will AcelRx Pharmaceuticals Inc (ACRX) Stock Go Next After It Is Up 31.65% in a Week?

The market has been high on AcelRx Pharmaceuticals Inc (ACRX) stock recently. ACRX gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bullish
AcelRx Pharmaceuticals Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on ACRX!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With ACRX Stock Today?

AcelRx Pharmaceuticals Inc (ACRX) stock is trading at $1.04 as of 11:02 AM on Friday, May 26, a rise of $0.09, or 9.48% from the previous closing price of $0.95. The stock has traded between $1.00 and $1.07 so far today. Volume today is 101,899 compared to average volume of 106,224. To screen for more stocks like AcelRx Pharmaceuticals Inc click here.

More About AcelRx Pharmaceuticals Inc

AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company's products under pipeline are ARX-02 and ARX-03. The majority of its revenue is generated from DSUVIA product sales in the United States. Click Here to get the full Stock Report for AcelRx Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App